The sympathetic system in hypertension. State-of-the-art review.
- 1 May 1982
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 4 (3_pt_2) , 208-225
- https://doi.org/10.1161/01.hyp.4.3_pt_2.208
Abstract
One may postulate a genetic defect in membrane permeability, in the transport of sodium, or in the sodium pump in vascular muscle which could account for increased intracellular sodium and enhanced vascular contractility. If the electrogenic sodium pump is overactive, as in SHR, its inhibition may lead to significant depolarization and greater contraction. Sympathetic innervation may be essential for the development of membrane abnormality as well as for the development of hypertrophic vascular changes, both of which augment contraction and vascular tone. A similar membrane defect at the sensory endings of arterial stretch receptors may account for impaired arterial baroreceptor reflexes seen in very early phases of hypertension or, in some genetic models, before hypertension develops. This defect may be related to the sodium pump or sodium transport in the receptor region and cause a decrease in baroreceptor discharge and in the strain-sensitivity of the baroreceptors, resulting in exaggerated sympathetic drive. Further information is needed on the baroreflex control of various efferents in hypertension. Another membrane defect at the adrenergic nerve terminals may facilitate release of endogenous NE. Excessive salt intake may unmask or exaggerate the membrane defects. In the central nervous system a defect in glutamine, NE, or GABA receptors may contribute to a high central sympathetic drive. Greater receptor affinity to various pressor neuropeptides such as angiotensin and leucine enkephalin or greater release of these peptides may also account for the excessive CNS sympathetic activation or impairment of baroreflexes at a central level. Cardiac receptors may have a variable influence on sympathetic drive in the various stages of hypertension, depending on the degree of cardiac hypertrophy or cardiac size. Finally, increased renal afferent nerve activity may provoke an increase in sympathetic activity and provide a link between natriuretic factors and the sympathetic nervous system in hypertension.Keywords
This publication has 91 references indexed in Scilit:
- Clonidine-Suppression TestNew England Journal of Medicine, 1981
- Increased Sodium-Lithium Countertransport in Red Cells of Patients with Essential HypertensionNew England Journal of Medicine, 1980
- Inherited defect in a Na+, K+ -co-transport system in erythrocytes from essential hypertensive patientsNature, 1980
- Resetting of cardiac C‐fiber endings in the spontaneously hypertensive ratActa Physiologica Scandinavica, 1979
- Humoral factors and the sodium-potassium pump in volume expanded hypertensionLife Sciences, 1979
- Production of sustained hypertension by lesions in the nucleus tractus solitarii of the American foxhound.Hypertension, 1979
- Increased erythrocyte permeability to Li and Na in the spontaneously hypertensive ratCellular and Molecular Life Sciences, 1976
- Altered permeability of the erythrocyte membrane for sodium and potassium ions in spontaneously hypertensive ratsPflügers Archiv - European Journal of Physiology, 1976
- Experimental hypertension of the rat: Reciprocal changes of norepinephrine turnover in heart and brain-stemNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1971
- Evidence for a central noradrenaline receptor stimulation by clonidineLife Sciences, 1970